Services was Nanobiotix’s largest revenue line in fiscal 2023, bringing in $29.75M of $30.16M (99%).
| Products and services [axis] | FY 2023 |
|---|---|
| Services | $29.75M |
| Other Sales | $308.00K |
| Technology Transfer | $100.00K |
| Total | $30.16M |
Nanobiotix brought in $30.16M from its three revenue lines in fiscal 2023, the year ended December 31, 2023. Services was the largest at $29.75M (98.6%), ahead of Other Sales at $308.00K (1.0%) and Technology Transfer at $100.00K (0.3%).
Nanobiotix (NBTX) reports its revenue by products and services [axis]. In fiscal 2023, Services was its largest revenue line, bringing in $29.75M (98.6% of the total), followed by Other Sales at $308.00K (1.0%).
Services was Nanobiotix's largest revenue line in fiscal 2023, bringing in $29.75M, or 98.6% of the $30.16M total across its three revenue lines.
Every figure comes from Nanobiotix's annual financial filings, as reported. Each line keeps the name Nanobiotix gives it, and years follow its fiscal calendar.
Nanobiotix's revenue by products and services [axis] goes back to fiscal 2023, with figures through fiscal 2023. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.